Open Access
| Issue |
Med Sci (Paris)
Volume 41, Number 8-9, Août-Septembre 2025
|
|
|---|---|---|
| Page(s) | 634 - 637 | |
| Section | Nouvelles | |
| DOI | https://doi.org/10.1051/medsci/2025103 | |
| Published online | 8 septembre 2025 | |
- Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discovery 2022 ; 12 : 31–46. [CrossRef] [PubMed] [Google Scholar]
- Shi H, Medler D, Wang J, et al. Suppression of melanoma by mice lacking MHC-II: Mechanisms and implications for cancer immunotherapy. J Exp Med 2024 ; 221 : e20240797. [Google Scholar]
- Durai V, Murphy KM. Functions of murine dendritic cells. Immunity 2016 ; 45 : 719–36. [CrossRef] [PubMed] [Google Scholar]
- Paolini L, Tran T, Corgnac S, et al. Differential predictive value of resident memory CD8+ T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy. J Immunother Cancer 2024 ; 12 : e009440. [Google Scholar]
- Zhou X, Jia X, Huang Z, et al. MHC class II regulation of CD8+ T cell tolerance and implications in autoimmunity and cancer immunotherapy. Cell Reports 2023 ; 42 : 113452. [Google Scholar]
- Johnson DB, Estrada MV, Salgado R, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun 2016 ; 7 : 10582. [Google Scholar]
- Shao XM, Huang J, Niknafs N, et al. HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade. Ann Oncol 2022 ; 33 : 728–38. [Google Scholar]
- Kreiter S, Vormehr M, van de Roemer N, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 2015 ; 520 : 692–6. [Google Scholar]
- Barry KC, Hsu J, Broz ML, et al. A natural killer/dendritic cell axis defines responsive tumor microenvironments in melanoma. Nat Med 2018 ; 24 : 1178–91. [CrossRef] [PubMed] [Google Scholar]
- Hildner K, Edelson BT, Purtha WE, et al. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 2008 ; 322 : 1097–100. [Google Scholar]
- Binnewies M, Mujal AM, Pollack JL, et al. Unleashing type-2 dendritic dells to drive protective antitumor CD4+ T cell immunity. Cell 2019 ; 177 : 556–71.e16. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.